Four key notes:
1. The collaboration allows Johnson & Johnson Medical Device’s orthopedics business, DePuy Synthes, to bring Tinavi’s spinal and trauma robotic solution to the China orthopedics implant market.
2. Tinavi’s robotic planform has approval from the National Medical Products Administration in China and includes a robotic arm, intraoperative planning interface and integrated navigation with intraoperative 3D imaging.
3. This agreement aligns with Johnson & Johnson’s goal to build a connected environment with technologies to enhance surgical performance, education and monitoring.
4. Tinavi is the only arm-based robotic technology that has multiple indications approved in China.
More articles on orthopedic devices:
Stryker closes $500M acquisition of Mobius Imaging, Cardan Robotics – 4 things to know
Texas hospital to build $40M orthopedic center, recruit up to 40 physicians
Life Spine, execs to settle FCA allegations for nearly $6M
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
